Researchers at the Peter Doherty Institute of Infections and Immunity in Melbourne, Australia, who development a potential step towards the vaccine, announced they will make the sample available in the WHO and laboratories worldwide.
The sample could be used to generate an antibody test, which would allow the virus to be detected in patients without symptoms, as well as the creation of a vaccine, as the institute said.
No comments:
Post a Comment